|
PLEKHA9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.01889999999328E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.902650E-03 |
| Normal-vs-Stage2 |
6.076400E-02 |
| Normal-vs-Stage3 |
2.221600E-02 |
| Normal-vs-Stage4 |
4.121900E-02 |
| Stage1-vs-Stage2 |
6.648400E-01 |
| Stage1-vs-Stage3 |
5.141800E-01 |
| Stage1-vs-Stage4 |
2.198600E-01 |
| Stage2-vs-Stage3 |
8.553200E-01 |
| Stage2-vs-Stage4 |
3.241800E-01 |
| Stage3-vs-Stage4 |
3.794400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.165120E-04 |
| Normal-vs-AfricanAmerican |
2.836700E-03 |
| Normal-vs-Asian |
5.810100E-02 |
| Caucasian-vs-AfricanAmerican |
6.910400E-01 |
| Caucasian-vs-Asian |
1.179630E-01 |
| AfricanAmerican-vs-Asian |
6.511500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.962500E-04 |
| Normal-vs-Female |
3.58790000000164E-05 |
| Male-vs-Female |
6.297600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.035900E-02 |
| Normal-vs-Extreme_Weight |
2.457900E-03 |
| Normal-vs-Obese |
1.224500E-03 |
| Normal-vs-Extreme_Obese |
2.914600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.900800E-01 |
| Normal_Weight-vs-Obese |
5.458000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.726400E-01 |
| Extreme_Weight-vs-Obese |
4.392200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.778200E-01 |
| Obese-vs-Extreme_Obese |
3.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.184910E-03 |
| Normal-vs-Age(41-60Yrs) |
4.46320000000444E-05 |
| Normal-vs-Age(61-80Yrs) |
5.419400E-04 |
| Normal-vs-Age(81-100Yrs) |
6.601000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.350200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.506600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.443700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.389600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.527700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.654040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.6046999999948E-05 |
| Normal-VS-Type2 PRCC |
5.698200E-02 |
| Normal-VS-KIRP CIMP |
2.86929999981922E-07 |
| Normal-VS-Unclassified PRCC |
8.457800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.357900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.977600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.372800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.897200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.638580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.193700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.427500E-02 |
| Normal-vs-N1 |
3.144300E-03 |
| Normal-vs-N2 |
1.07760000034318E-07 |
| N0-vs-N1 |
3.982400E-02 |
| N0-vs-N2 |
8.39100000000759E-05 |
| N1-vs-N2 |
1.176390E-01 |
|
|
